Form D · Pharmaceuticals
Verrica Pharmaceuticals Inc.
West Chester, PA · CIK 0001660334
Offering snapshot reported Dec 10, 2025 · SEC filing
- Reported sold
- $50M Offering amount: $50M
- Investors reported
- 21 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Nov 25, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 10, 2025 | Initial | $50,017,383 | No comparison | 21 | SEC filing |
| Feb 21, 2018 | Initial | $19,999,995 | No comparison | 2 | SEC filing |
| Dec 22, 2017 | Initial | $5,000,000 | No comparison | 1 | SEC filing |
| Dec 17, 2015 | Initial | $2,434,186 | No comparison | 14 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $500K
- Finders' fees
- $0
- Form D file number
- 021-566413
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| TD Securities (USA) LLC | 18476 |
Source: Form D, filed Dec 10, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Joseph Bonaccorso | Executive |
| Anthony Cavallo | Executive |
| Gavin Corcoran | Director |
| Matthew Davidson | Director, Executive, Promoter |
| Lawrence Eichenfield | Director |
| John Kirby | Executive |
| Paul B. Manning | Director |
| Diem Nguyen | Director |
| Glenn Oclassen | Director, Promoter |
| Mark Prygocki | Director |
| James C. Reebals | Executive, Promoter |
| Jayson Rieger | Director, Executive |
| Noah Rosenberg | Executive |
| Sean Stalfort | Director |
| Ted White | Executive |
| David Zawitz | Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
44 W. Gay St., Suite 400
West Chester, PA, 19380
Phone: 484-453-3300
West Chester, PA, 19380
Phone: 484-453-3300